| Dr Manqian Tu, OD | |
|
920 Revolution St, Havre De Grace, MD 21078-3748 | |
| (410) 939-2200 | |
| (410) 939-5980 |
| Full Name | Dr Manqian Tu |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 920 Revolution St, Havre De Grace, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801855630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG001427 (Pennsylvania) | Secondary |
| 152W00000X | Optometrist | TA2455 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Myeyedr Optometry Of Maryland Llc | 6002037629 | 61 |
News Archive
More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD).
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 1 days ago
| Provider Name | Lisa K Feulner Md Phd Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932256039 PECOS PAC ID: 3072513605 Enrollment ID: O20070105000154 |
News Archive
More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD).
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 1 days ago
| Provider Name | Myeyedr Optometry Of Maryland Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609204437 PECOS PAC ID: 6002037629 Enrollment ID: O20141024000821 |
News Archive
More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD).
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manqian Tu, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: (703) 847-8899 | Dr Manqian Tu, OD 920 Revolution St, Havre De Grace, MD 21078-3748 Ph: (410) 939-2200 |
News Archive
More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD).
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bernama reports.
› Verified 1 days ago
Holloway Eye Care & Optique Optometrist Medicare: Medicare Enrolled Practice Location: 2015-c Pulaski Highway, Havre De Grace, MD 21078 Phone: 410-939-7717 Fax: 410-939-7739 | |
Dr. Scott Michael Smearman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Highway, Havre De Grace, MD 21078 Phone: 410-939-6477 Fax: 410-939-6555 | |
Meredith Katherine Clark, O. D. Optometrist Medicare: Medicare Enrolled Practice Location: 920 Revolution St, Havre De Grace, MD 21078 Phone: 410-939-2200 Fax: 410-939-5980 | |
Dr. Jessica A Wieser, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 Fax: 410-939-6555 | |
Jayro Loya Grijalva, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 | |
Dr. David D Reed, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Highway, Havre De Grace, MD 21078 Phone: 410-939-6477 Fax: 410-939-6555 | |
Dr. Patricia Vivian Jones, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 |